News
The projected fair value for Braze is US$36.93 based on 2 Stage Free Cash Flow to Equity. Current share price of US$33.66 suggests Braze is potentially trading close ...
Key Insights Using the 2 Stage Free Cash Flow to Equity, Cosmo Pharmaceuticals fair value estimate is CHF80.81 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results